PTBP1-mediated inhibition of circular RNA SCMH1 biogenesis impairs brain recovery after ischemic stroke

Ying Bai1, Bing Han1,2, Yi Zhang1

  • 1Department of Pharmacology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Medicine, Southeast University, Nanjing 210009, China.

Theranostics
|December 2, 2025
PubMed
Abstract

Insights

Polypyrimidine tract binding protein 1 (PTBP1) suppresses circSCMH1 production by inhibiting back-splicing. This regulation impacts brain repair after stroke, offering potential therapeutic targets for stroke recovery.

Area of Science:

  • Molecular Biology
  • Genetics
  • Neuroscience

Background:

  • Aberrant circular RNA (circRNA) expression is linked to various diseases.
  • Mechanisms regulating circRNA biogenesis are not fully understood.
  • circSCMH1 was previously identified as a circRNA associated with brain repair.

Purpose of the Study:

  • Investigate the regulatory mechanisms of circSCMH1 biogenesis.
  • Identify RNA-binding proteins (RBPs) that regulate circSCMH1.
  • Determine the role of PTBP1 in circSCMH1 production and its impact on stroke.

Main Methods:

  • Computational analysis of RBP binding sites in intronic regions.
  • Transcriptomic sequencing to identify circRNA regulators.
  • RNA immunoprecipitation and functional assays to validate RBP-circRNA interactions.

Main Results:

  • Polypyrimidine tract binding protein 1 (PTBP1) binds to circSCMH1 precursor sequences.
  • PTBP1 binding inhibits back-splicing, reducing circSCMH1 production.
  • PTBP1-mediated suppression of circSCMH1 worsens post-stroke brain injury.

Conclusions:

  • PTBP1 is a novel regulator of circSCMH1 biogenesis via suppression of back-splicing.
  • This study elucidates a new circRNA regulatory mechanism.
  • Findings suggest PTBP1 and circSCMH1 as potential therapeutic targets for stroke recovery.